NEW YORK, United States, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Fabry Disease Treatment Market By Treatment (Substrate Reduction Therapy, Enzyme Replacement Therapy, Chaperone Treatment, And Others), By Caregiver Type (Hospitals, Specialty Clinics, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.
“According to the latest research study, the demand of global Fabry Disease Treatment Market size & share in terms of revenue was valued at USD 1904.27 million in 2022 and it is expected to surpass around USD 3342.65 million mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 7.26% during the forecast period 2023 to 2030.”
What is Fabry Disease Treatment? How big is the Fabry Disease Treatment Industry?
Fabry Disease Treatment Report Coverage & Overview:
Fabry disease is a hereditary condition passed down from parents to their children. It is caused by the accumulation of a type of fat called globotriaosylceramide. Symptoms of the disease typically manifest in early childhood. Some of the most commonly observed signs include recurrent episodes of pain, especially concentrated in areas like the hands and feet, clusters of small, dark, red spots on the skin known as angiokeratomas, hazy vision, reduced ability to sweat (known as hypohidrosis), and ringing in the ears. Patients may also experience hearing loss and gastrointestinal issues. However, it's important to note that these symptoms can vary from one patient to another, and specific groups may exhibit additional signs. If left untreated or undiagnosed, Fabry disease can lead to severe and potentially life-threatening complications such as stroke, heart failure, and progressive kidney disease. Some individuals with the condition may display milder symptoms that appear later in adulthood and may be localized to specific areas such as blood vessels in the brain, kidneys, or heart.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/fabry-disease-treatment-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- About 199+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Global Fabry Disease Treatment Market: Growth Dynamics
The increasing prevalence of Fabry disease is expected to drive greater demand for its treatment.
The global Fabry disease treatment market is poised for growth due to the escalating prevalence of this condition. Research analysis indicates that Fabry disease affects approximately 1 in 1,000 to 9,000 individuals. With a rising global population, the likelihood of the condition being passed on to newborns, given its hereditary nature, is also increasing. Recent observations suggest that the development of milder symptoms with age is more common than the manifestation of severe forms of the disease. Additionally, Fabry disease can affect individuals of all ethnic backgrounds and genders, broadening the spectrum of patients it impacts. Furthermore, there is a growing awareness of Fabry disease, with increased discussions within the scientific and medical communities. This heightened awareness is leading to earlier diagnoses, which play a pivotal role in further driving market revenue.
Moreover, ongoing innovations in diagnostic technologies are set to propel the industry's expansion. Fabry disease has historically been underdiagnosed, and until recently, accurate diagnostic tools for its precise detection were challenging to come by. However, with the continuous advancements in the medical and healthcare sectors, more efficient and accurate diagnostic methods have emerged. For example, in August 2018, PerkinElmer received approval from the US Food and Drug Administration (FDA) for the commercial sale of the NeoLSD MSMS Kit. This innovative tool is capable of detecting approximately six lysosomal storage disorders, including Fabry disease, in newborns, and it can be easily conducted using blood samples.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/fabry-disease-treatment-market
Report Scope
| Report Attribute | Details |
| Market Size in 2022 | USD 1904.27 million |
| Projected Market Size in 2030 | USD 3342.65 million |
| CAGR Growth Rate | 7.26% CAGR |
| Base Year | 2022 |
| Forecast Years | 2023-2030 |
| Key Market Players | JCR Pharmaceuticals, Sanofi Genzyme, Green Cross Corporation, Chiesi Group, Regenxbio Inc., Protalix BioTherapeutics, Idorsia Pharmaceuticals, Amicus Therapeutics, and others. |
| Key Segment | By Treatment, By Treatment, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Fabry Disease Treatment Market: Segmentation Analysis
The global Fabry disease treatment market is categorized based on treatment options, caregiver types, and geographical regions.
In terms of treatment options, the market can be divided into substrate reduction therapy, enzyme replacement therapy, chaperone treatment, and other therapeutic approaches. Notably, in 2022, the highest demand was witnessed for enzyme replacement therapy (ERT) due to its widespread acceptance across various countries, including Europe and North America. The increasing adoption of ERT-focused treatment regimens has contributed to the growth of this segment. For instance, the use of Fabrazyme as part of ERT aids in restoring alpha-galactosidase A levels, facilitating the breakdown of lipids and providing relief from Fabry disease-related symptoms. It's worth noting that the average life expectancy for male patients is approximately 58 years.
Regarding caregiver types, the Fabry disease treatment industry is segmented into hospitals, specialty clinics, and other healthcare facilities. Notably, in 2022, the hospitals segment exhibited the highest growth rate. Hospitals tend to have a higher patient influx and are better equipped to provide a wide range of treatments. Moreover, they have access to advanced diagnostic tools and a wealth of medical expertise. The growth of this segment may be further fueled by increasing investments in healthcare infrastructure. Within the European Union alone, there are more than 15,000 hospitals.
The global Fabry Disease Treatment market is segmented as follows:
By Treatment
- Substrate Reduction Therapy
- Enzyme Replacement Therapy
- Chaperone Treatment
- Others
By Caregiver Type
- Hospitals
- Specialty Clinics
- Others
Browse the full “Fabry Disease Treatment Market By Treatment (Substrate Reduction Therapy, Enzyme Replacement Therapy, Chaperone Treatment, And Others), By Caregiver Type (Hospitals, Specialty Clinics, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” Report at https://www.zionmarketresearch.com/report/fabry-disease-treatment-market
Competitive Landscape
Some of the main competitors dominating the global Fabry Disease Treatment market include -
- JCR Pharmaceuticals
- Sanofi Genzyme
- Green Cross Corporation
- Chiesi Group
- Regenxbio Inc.
- Protalix BioTherapeutics
- Idorsia Pharmaceuticals
- Amicus Therapeutics
Key Insights from Primary Research:
- As per the analysis shared by our research analyst, the global Fabry disease treatment market is estimated to grow annually at a CAGR of around 7.26% over the forecast period (2023-2030)
- In terms of revenue, the global Fabry disease treatment market size was valued at around USD 1904.27 million in 2022 and is projected to reach USD 3342.65 million, by 2030.
- The Fabry market is projected to grow at a significant rate due to the increasing prevalence of Fabry disease to create higher demand
- Based on caregiver type segmentation, hospitals were predicted to show maximum market share in the year 2022
- Based on treatment segmentation, enzyme replacement therapy was the leading segment in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/fabry-disease-treatment-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Fabry Disease Treatment industry?
- What are the main driving factors propelling the Fabry Disease Treatment Market forward?
- What are the leading companies in the Fabry Disease Treatment Industry?
- What segments does the Fabry Disease Treatment Market cover?
- How can I receive a free copy of the Fabry Disease Treatment Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Treatment, By Treatment, and By Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7627
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
North America is expected to experience the highest growth rate in the near future within the global Fabry disease treatment market. This projection is primarily due to the presence of a robust healthcare infrastructure in the United States. The pharmaceutical industry in the region is known for its innovation-driven approach, focusing on the development of novel medical treatments for a wide range of medical conditions. Additionally, the increasing rate of FDA approvals for Fabry disease treatments has played a pivotal role in maintaining North America's dominance in this market. For instance, in September 2022, the FDA granted Orphan Drug Designation (ODD) to AL01211, developed by AceLink Therapeutics, as a treatment for Fabry disease. This particular treatment, a glucosylceramide synthase (GCS) inhibitor, has exhibited high potency and is notable for being an orally administered medication, addressing a significant need compared to other available treatments.
In contrast, Europe is also projected to witness substantial growth in the Fabry disease treatment market. In May 2023, Europe granted marketing authorization to Chiesi Farmaceutici and Protalix BioTherapeutics for their product PRX-102 (pegunigalsidase alfa) as a treatment for Fabry disease within the European territory. This approval further contributes to the expansion of treatment options for Fabry disease patients in the region.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/fabry-disease-treatment-market
Browse Other Related Research Reports from Zion Market Research:
Electric Arc Furnace (EAF) Dust Recycling Market By Process (Pyrometallurgy And Hydrometallurgy), By Application (Zinc, Iron, Lead, And Others), By End User Industry (Chemical Industry, Cement Industry, Steel Industry, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/electric-arc-furnace-eaf-dust-recycling-market
Commercial Seaweed Market By Product (Brown Seaweed, Red Seaweed, And Green Seaweed), By Form (Leaf, Powdered, And Flakes), By Application (Agriculture, Animal Feed, Human Consumption, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/commercial-seaweed-market
Black Mass Recycling Market By Battery Source (Automotive Batteries, Industrial Batteries, And Portable Batteries), By Technology (Hydrometallurgy, Pyrometallurgy, And Others), By Recovered Metal (Nickel, Cobalt, Lithium, Copper, Manganese, And Others), By Application (Automotive, Consumer Electronics, Energy, Aerospace And Defense, Construction, And Others) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/black-mass-recycling-market
Virtual Schools Market - By Type (For-Profit EMO And Non-Profit EMO), By Application (Elementary Schools, High Schools, Adult Education, And Middle Schools), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/virtual-schools-market
Confidential Computing Market - By Component (Hardware, Services, And Software), By Vertical (BFSI, IT &Telecom, Healthcare, Retail & E-Commerce, Manufacturing, Government & Public Sector, And Others), By Deployment Mode (On-Premise And Cloud), By Application (Data Security, Secure Enclaves, Pellucidity Between Users, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/confidential-computing-market
Single Vision Lenses Market By Type (Spherical, Aspherical, And Freeform), By Material (Glass, Polycarbonate, And Other Material Types), By Age Group (< 18 Years, >= 18 Years & < 40 Years, And >= 40 Years), By Application (Hyperopia (Farsightedness), Myopia (Nearsightedness), Astigmatism, And Presbyopia), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/single-vision-lenses-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
India: +91 7768 006 007, +91 7768 006 008
Skype no: +13479038971, +17187054574
Skype no. United Kingdom: +442032894158
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: sales@zionmarketresearch.com
